Ticker
ORGOCompany Name
ORGANOGENESIS HOLDINGS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 3.01M | 0.7% | $ 429.53M |
3/31/2025 | $ 1.3M | 0.28% | $ 458.76M |
12/31/2024 | $ 24.11M | 5% | $ 482.04M |
9/30/2024 | $ 12.54M | 2.75% | $ 455.04M |
6/30/2024 | $ 13.75M | 3.07% | $ 448.39M |
3/31/2024 | $ 36.49M | 8.38% | $ 435.47M |
12/31/2023 | $ 36.03M | 8.32% | $ 433.14M |
9/30/2023 | $ 44.27M | 9.86% | $ 449M |
6/30/2023 | $ 36.64M | 8.01% | $ 457.33M |
3/31/2023 | $ 37.92M | 8.22% | $ 461.42M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA / Revenues
(=) EBITDA %
EBITDA % for ORGANOGENESIS HOLDINGS INC is calculated as follows: EBITDA [ $ 13.85M ] / Revenues [ $ 306.14M ]
(=) EBITDA % [ 4.52% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.29K |
---|---|
min | -75.07% |
max | 97.73% |
average | 16.12% |
median | 14.72% |
std | 26.88% |